The Activity of SV40 Promoter Can Be Inhibited by Overexpression of Heme Oxygenase-1 in Tumor Cells

Cell Biochemistry and Biophysics

Volumn 65, Issue 3, 2013, Pages 287-295

  Liu, Qingjun ^a   Yin, Yujing ^a   Wang, Bo ^a   Zhou, Hong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Early promoter activity; Heme oxygenase 1; Simian Virus 40

Indexed keywords

SIMIAN VIRUS 40;

EID: 84875230433     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9431-5     Document Type: Article

References (31)

1. Jozkowicz, A., Was, H., & Dulak, J. (2007). Heme oxygenase-1 in tumors: Is it a false friend? Antioxidants and Redox Signaling, 9, 2099-2117.
2. Lad, L., Koshkin, A., de Montellano, P. R., & Poulos, T. L. (2005). Crystal structures of the G139A, G139A-NO and G143H mutants of human heme oxygenase-1. A finely tuned hydrogen-bonding network controls oxygenase versus peroxidase activity. Journal of Biological Inorganic Chemistry, 10, 138-146.
3. Liu, Y., Koenigs Lightning, L., Huang, H., Moenne-Loccoz, P., Schuller, D. J., Poulos, T. L., et al. (2000). Replacement of the distal glycine 139 transforms human heme oxygenase-1 into a peroxidase. The Journal of Biological Chemistry, 275, 34501-34507.
4. Chung, S. W., Hall, S. R., & Perrella, M. A. (2009). Role of haem oxygenase-1 in microbial host defence. Cellular Microbiology, 11, 199-207.
5. Otterbein, L. E., May, A., & Chin, B. Y. (2005). Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR)4 expression. Cellular and Molecular Biology, 51, 433-440.
6. Overhaus, M., Moore, B. A., Barbato, J. E., Behrendt, F. F., Doering, J. G., & Bauer, A. J. (2006). Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290, G695-G703.
7. Chung, S. W., Liu, X., Macias, A. A., Baron, R. M., & Perrella, M. A. (2008). Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. The Journal of Clinical Investigation, 118, 239-247.
8. Protzer, U., Seyfried, S., Quasdorff, M., Sass, G., Svorcova, M., Webb, D., et al. (2007). Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology, 133, 1156-1165.
9. Zhu, Z., Wilson, A. T., Mathahs, M. M., Wen, F., Brown, K. E., Luxon, B. A., et al. (2008). Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology, 48, 1430-1439.
10. Devadas, K., & Dhawan, S. (2006). Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. Journal of Immunology, 176, 4252-4257.
11. Muhl, H., Paulukat, J., Hofler, S., Hellmuth, M., Franzen, R., & Pfeilschifter, J. (2004). The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells. British Journal of Pharmacology, 143, 890-898.
12. Hashiba, T., Suzuki, M., Nagashima, Y., Suzuki, S., Inoue, S., Tsuburai, T., et al. (2001). Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Therapy, 8, 1499-1507.
13. McAllister, S. C., Fruh, K., & Moses, A. V. (2005). Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma. Pharmacogenomics, 6, 235-244.
14. Shiloh, M. U., Manzanillo, P., & Cox, J. S. (2008). Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host and Microbe, 3, 323-330.
15. Epiphanio, S., Mikolajczak, S. A., Goncalves, L. A., Pamplona, A., Portugal, S., Albuquerque, S., et al. (2008). Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host and Microbe, 3, 331-338.
16. Klein, G., Powers, A., & Croce, C. (2002). Association of SV40 with human tumors. Oncogene, 21, 1141-1149.
17. Jasani, B., Cristaudo, A., Emri, S. A., Gazdar, A. F., Gibbs, A., Krynska, B., et al. (2001). Association of SV40 with human tumours. Seminars in Cancer Biology, 11, 49-61.
18. Gazdar, A. F., Butel, J. S., & Carbone, M. (2002). SV40 and human tumours: Myth, association or causality? Nature Reviews Cancer, 2, 957-964.
19. Zwicker, J., Korner, K., & Muller, R. (1999). The SV40 large T oncoprotein disrupts DNA-binding of the cell cycle-regulated transcriptional repressor CDF. Oncogene, 18, 2023-2025.
20. Zheng, H. C., Nakamura, T., Zheng, Y., Nakanishi, Y., Tabuchi, Y., Uchiyama, A., et al. (2009). SV40 T antigen disrupted the cell metabolism and the balance between proliferation and apoptosis in lens tumors of transgenic mice. Journal of Cancer Research and Clinical Oncology, 135, 1521-1532.
21. Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., et al. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genetics, 33, 401-406.
22. Karolewski, B. A., Watson, D. J., Parente, M. K., & Wolfe, J. H. (2003). Comparison of transfection conditions for a lentivirus vector produced in large volumes. Human Gene Therapy, 14, 1287-1296.
23. Ryter, S. W., Si, M., Lai, C. C., & Su, C. Y. (2000). Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. American Journal of Physiology. Heart and Circulatory Physiology, 279, H2889-H2897.
24. Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996). Heme oxygenase: A novel target for the modulation of the inflammatory response. Nature Medicine, 2, 87-90.
25. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., et al. (2002). Pro-oxidant and cytotoxic effects of circulating heme. Blood, 100, 879-887.
26. Morse, D., Pischke, S. E., Zhou, Z., Davis, R. J., Flavell, R. A., Loop, T., et al. (2003). Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. The Journal of Biological Chemistry, 278, 36993-36998.
27. Alam, J., & Den, Z. (1992). Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. The Journal of Biological Chemistry, 267, 21894-21900.
28. Lin, Q., Weis, S., Yang, G., Weng, Y. H., Helston, R., Rish, K., et al. (2007). Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. The Journal of Biological Chemistry, 282, 20621-20633.
29. Sacca, P., Meiss, R., Casas, G., Mazza, O., Calvo, J. C., Navone, N., et al. (2007). Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. British Journal of Cancer, 97, 1683-1689.
30. Hori, R., Kashiba, M., Toma, T., Yachie, A., Goda, N., Makino, N., et al. (2002). Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. The Journal of Biological Chemistry, 277, 10712-10718.
31. Soares, M. P., Seldon, M. P., Gregoire, I. P., Vassilevskaia, T., Berberat, P. O., Yu, J., et al. (2004). Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. Journal of Immunology, 172, 3553-3563.